Jupiter Research Capital (Asia) Ltd’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$65.9K Buy
+17,816
New +$66.8K 0.01% 662

Other funds holding FULC

Jupiter Research Capital (Asia) Ltd's FULC Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd opened a new position in Fulcrum Therapeutics (FULC) in Q3 2026: 17,816 shares worth $65.9K. The stake represents 0.01% of the portfolio and ranks #662 among its holdings.

145 funds tracked by Wall St. Rank hold FULC as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 17,816 shares of Fulcrum Therapeutics worth $65.9K as of Q3 2026.
  • Fulcrum Therapeutics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
  • Fulcrum Therapeutics made up 0.01% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #662 holding.
  • 145 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.